VS
stockvs
Go to ScreenerHub
JNJ

JNJ vs MRK

MRK

In the past 12 months, JNJ returned +49% while MRK gained 22%.

JNJ
JNJ

Johnson & Johnson

$243.19
-0.1%(1M)
Market Cap586.1B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio22.08
ROE33.8%
P/B Ratio7.26
Dividend Yield2.1%
MRK
MRK

Merck & Co., Inc.

$115.42
-5.1%(1M)
Market Cap285.4B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio15.97
ROE36.2%
P/B Ratio5.54
Dividend Yield2.8%
Performance Comparison

Historical returns across multiple timeframes

JNJ

JNJ

Johnson & Johnson

+49.3%

1Y Return

MRK

MRK

Merck & Co., Inc.

+21.8%

1Y Return

JNJ
JNJ
MRK
MRK

Short Term

1M-6M

MRK
+18.2%

Medium Term

YTD-1Y

JNJ
+33.3%

Long Term

3Y-10Y

JNJ
+78.3%

Valuation

Compare price multiples and valuation ratios

JNJ: 0MRK: 5
MetricJNJMRKWinner
P/E Ratio

Price to earnings ratio

22.0815.97MRK
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

6.244.45MRK
P/B Ratio

Price to book ratio

7.265.54MRK
P/FCF Ratio

Price to free cash flow ratio

29.8223.42MRK
EV/EBITDA

Enterprise value to EBITDA

15.3612.34MRK
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

JNJ: 2MRK: 4
MetricJNJMRKWinner
Gross Margin

Gross profit margin

72.8%81.5%MRK
Operating Margin

Operating profit margin

27.2%41.2%MRK
Net Margin

Net profit margin

28.5%28.1%JNJ
ROE

Return on equity

33.8%36.2%MRK
ROA

Return on assets

13.5%13.3%JNJ
ROIC

Return on invested capital

13.7%20.8%MRK

Growth

Compare revenue and earnings growth rates

JNJ: 4MRK: 2
MetricJNJMRKWinner
Revenue Growth (YoY)

Year-over-year revenue growth

6.0%1.3%JNJ
Revenue Growth (3Y)

3-year revenue CAGR

5.6%3.1%JNJ
Revenue Growth (5Y)

5-year revenue CAGR

2.7%9.4%MRK
EPS Growth (YoY)

Year-over-year EPS growth

90.5%8.0%JNJ
EPS Growth (3Y)

3-year EPS CAGR

17.9%8.4%JNJ
EPS Growth (5Y)

5-year EPS CAGR

14.9%21.2%MRK

Balance Sheet & Risk

Compare financial stability and debt levels

JNJ: 1MRK: 4
MetricJNJMRKWinner
Debt/Equity

Debt to equity ratio

0.590.96JNJ
Current Ratio

Current assets to current liabilities

1.031.54MRK
Quick Ratio

Quick assets to current liabilities

0.771.30MRK
Interest Coverage

EBIT to interest expense

26.3628.34MRK
Beta

Stock volatility vs market

0.330.26MRK
Summary
MRK wins 3-1

Valuation

MRK

Profitability

MRK

Growth

JNJ

Balance Sheet

MRK

MRK is more attractively valued. MRK shows stronger profitability. JNJ demonstrates better growth. MRK has a stronger balance sheet.

Take Your Analysis Further

Dive deeper into JNJ and MRK with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/JNJ/vs/MRK" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare JNJ vs MRK on stockvs.app
</a>